VersAI’s Unique Neural Network Architecture Marks a Major Leap Forward for Drug Discovery AI

Drug Discovery World’s editor Reece Armstrong and Verseon’s CEO Adityo Prakash discuss the implications of different AI neural network architectures for drug discovery